← SEC 公告列表 | SSII SEC 公告 | SS Innovations International, Inc.(SSII)

重大事件 即時報告 8-K 2026-07-07

SS Innovations 旗下培訓課程完成,33名國際學員畢業推動機械人手術普及

於 SEC 網站開啟原文

AI 繁中摘要

SS Innovations (NASDAQ: SSII) 子公司 SS International Centre for Robotics Surgery (SSICRS) 剛於 2026 年 7 月 7 日宣佈,其首屆心臟機械人手術培訓課程已順利完成,33 名來自 7 個國家的學員正式畢業 🎓。課程為期五天,由 16 位國際級導師授課,涵蓋全內鏡冠狀動脈搭橋、左內乳動脈搭橋、心房中隔缺損修補及二尖瓣手術等機械人技術。培訓形式包括現場手術示範、實機操作、虛擬視像環節及科學討論,學員並在 SSi Mantra 機械人系統上進行模擬練習。 SS Innovations 主席兼行政總裁 Dr. Sudhir Srivastava 表示,SSICRS 定位為全球頂尖機械人手術教育機構,目標是「普及機械人手術教育,惠及所有醫生與病人,不論身處何地」。他強調課程融合課堂理論與實驗室訓練,旨在提供更精細、更安全的機械人護理技能。SSICRS 的設施配備現代化講堂及仿真手術室,未來將持續推出多專科五天課程,涵蓋心臟、泌尿、婦科、胸腔、結直腸、胃腸及普通外科等領域,並提供遙距指導及網上模組作靈活學習。 是次培訓導師來自美國芝加哥大學醫學中心、克利夫蘭診所、比利時 OLV 診所、韓國 Asan Medical Center 等知名機構,顯示 SSi Mantra 系統獲國際專家認可。此舉有助 SS Innovations 擴大 SSi Mantra 的臨床應用網絡,推動全球機械人手術普及,對投資者而言,教育計劃可望加速系統採用率及未來收入增長。公司提醒,新聞稿內含前瞻性陳述,實際結果或與預期有別。
展開英文正文
EX-99.1
2
ea029721101ex99-1.htm
PRESS RELEASE, DATED JULY 7, 2026

 

Exhibit 99.1

 

 

SS Innovations Subsidiary SSICRS Graduates Inaugural
Cardiac Robotic Surgery Training Class

 

New course empowers healthcare professionals
through expert instruction and hands-on learning

 

Fort
Lauderdale, FL – July 7, 2026 – SS Innovations International, Inc. (the “Company” or “SS
Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable
and accessible to a global population, today announced that the Company’s subsidiary, the SS International Centre for Robotics
Surgery (“SSICRS”), has graduated its first class in a specialized training course designed to provide surgeons
and other healthcare professionals with classroom instruction and hands-on learning in robotic-assisted cardiac surgery using the advanced
SSi Mantra surgical robotic system (the “SSi Mantra”) at SSICRS’s facilities at the Company’s headquarters
in Gurugram, India.

 

 
 An inaugural class of 33 participants from seven countries graduated
from Cardiac Robotic Surgery Training, the opening course in SSICRS’s new training program. The course featured 16 distinguished
international faculty members to create a global platform for education, collaboration, and innovation in robotic cardiac surgery. Training
covered robotic procedures such as totally endoscopic coronary artery bypasses, left internal mammary artery bypasses, atrial septal defects,
and mitral valve surgery. The course consisted of live surgical demonstrations, hands-on robotic training, virtual video sessions, scientific
discussions, and knowledge exchange.
  
 

 (Cardiac
 training session at SSICRS’s facilities in India)

 

 

Dr. Sudhir Srivastava, Chairman of the Board and
Chief Executive Officer of SS Innovations, commented, “We congratulate the graduates of SSICRS’s inaugural course, Cardiac
Robotic Surgery Training, and look forward to shaping the future of robotic surgery with ongoing immersive multi-specialty training
courses. We are positioning SSICRS as one of the world’s premier educational institutes for robotic surgery. SSICRS brings together
top-tier faculty, modern lecture halls, state-of-the-art labs, and the advanced SSi Mantra surgical robotic system to train global healthcare
professionals in robotic surgery. SSICRS’s balance of classroom theory and lab training is designed to deliver nuanced skills and
smarter, safer surgical robotic care. SSICRS strives to democratize robotic surgery education for the benefit of all practitioners and
patients, regardless of location, and we look forward to providing continuous specialized learning and mentorship opportunities.”

 

SSICRS’s ongoing training program will consist
of numerous condensed, five-day courses that focus on multi-specialty learning opportunities across cardiac, urologic, gynecologic, thoracic,
colorectal, gastrointestinal, and general surgery, among other procedures, leveraging the SSi Mantra platform as a training tool.

 

  

  

 

 

International
members of SSICRS’s faculty include: 

 

●Dr.
 Husam Balkhy, The University of Chicago Medicine and Biological Sciences (United States)

 

●Dr.
 T Sloane Guy, Georgia Heart Institute (United States)

 

●Dr.
 Frank Van Praet, OLV Clinic (Belgium) 

 

●Dr.
 Rakesh M. Suri, Corewell Health (United States)

 

●Dr.
 Jae Won Lee, Asan Medical Center (South Korea)

 

●Dr.
 Gianluca Torregrossa, Cleveland Clinic (United States)

 

●Dr.
 Nirav Patel, Lenox Hill Hospital (United States)

 

●Dr.
 Danny Ramzy, Memorial Hermann — Memorial City Medical Center (United States)

 

SSICRS’s
facilities feature modern lecture halls for holding interactive sessions, case discussions and expert talks as well as state-of-the-art
training labs that mirror real-world operating rooms and surgical conditions. During lab sessions, participants utilize the SSi Mantra
surgical robotic system for performing mock procedures on tissue models and practicing instrument handling, suturing, and dissection
on synthetic models. Tele-proctoring, engineering-integrated learning and live surgery observations add value to the curriculum. Additionally,
SSICRS offers separate online modules that complement in-person classes with flexible, self-paced learning, pre-training sessions, recorded
lectures, quizzes, and ongoing support.

 

For an SSICRS video welcome message from the Company’s
CEO, Dr. Srivastava, please click here.

 

About SS Innovations

 

SS Innovations International, Inc. (Nasdaq: SSII)
develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a
larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical
robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic
procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence
of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com
or LinkedIn for more information and updates.

 

About the SSi Mantra

 

The SSi Mantra surgical robotic system is a user-friendly,
modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command
center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic
patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon
console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that provides equivalent control
functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40
different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments
for the pediatric population and ENT surgeries. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon
to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 170 different types of surgical
procedures.

 

 2

  

 

 

Forward Looking Statements

 

This press release may contain statements that
are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.
The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,”
“intend,” “may,” “plan,” “project,” “should,” “could,” “seek,”
“designed,” “potential,” “forecast,” “target,” “objective,” “goal,”
or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future
events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that
may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels
of activity, performance or achievements expressed or implied by these forward-looking statements.

 

Investor Contact:

 

The Equity Group

Kalle Ahl, CFA

T: (303) 953-9878

[email protected]

 

Devin Sullivan, Managing Director

T: (212) 836-9608

[email protected]

 

Media Contact:

 

RooneyPartners LLC

Kate Barrette

T: (212) 223-0561

[email protected]

 

 3